NCT07060664

Brief Summary

Patients undergoing either operative or non-operative treatment of proximal humerus fractures will be studied with the goal of understanding which treatment modality provides optimal post-injury outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
22mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 11, 2025

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

October 20, 2025

Status Verified

October 1, 2025

Enrollment Period

1.7 years

First QC Date

June 29, 2025

Last Update Submit

October 15, 2025

Conditions

Keywords

proximal humerus fracturehumerusfractureshoulderORIFIMNnailopen reduction internal fixation

Outcome Measures

Primary Outcomes (9)

  • Range of Motion (ROM)

    Range of Motion of the shoulder in terms of degrees of motion Assessment of forward flexion (0-180 degrees), abduction (0-90 degrees), external rotation (0-90 degrees)

    at 3 months, 6 months, 12 months, and 24 months from initiation of treatment

  • SANE

    "Sane outcome" typically refers to the Single Assessment Numeric Evaluation (SANE) score, a patient-reported outcome measure used in healthcare, particularly in orthopedics. It assesses a patient's perceived function of a joint or body region by asking them to rate it on a scale of 0 to 100, where 100 represents normal function

    at 3 months, 6 months, 12 months, and 24 months following initiation of treatment

  • VAS

    "VAS outcome" refers to the results obtained from using a Visual Analog Scale (VAS). The VAS is a measurement tool, typically a 10 cm or 100 mm line, where individuals indicate the intensity of a subjective experience, such as pain, by marking a point on the line. The distance from one end of the line to the patient's mark is then measured, and this measurement represents the VAS score. A higher score indicates a greater intensity of the experience being measured.

    at 3 months, 6 months, 12 months, and 24 months following initiation of intervention

  • ASES

    The American Shoulder and Elbow Surgeons scale (ASES) is a condition-specific scale that is intended to measure functional limitations and pain of the shoulder. A higher ASES score indicates better shoulder function and less pain, with a score of 100 representing the best possible outcome and a score of 0 representing the worst possible outcome.

    at 3 months, 6 months, 12 months, and 24 months following initiation of intervention

  • EQ-5D-5L

    The EQ-5D-5L score represents a patient's self-reported health status, with values ranging from -0.59 to 1, where 1 indicates the best possible health. It's based on five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with five levels of severity. These responses are converted into a single index score using a scoring algorithm.

    at baseline and subsequently at 3 months, 6 months, 12 months, and 24 months following initiation of intervention

  • Brophy/Marx

    The Brophy-Marx Shoulder Activity Score is a valid and reliable shoulder-specific questionnaire that measures a patient's shoulder activity level over the previous year. The questionnaire generates a numeric score from 0 (least active) to 20 (most active).

    at baseline and subsequently at 12 months and 24 months after initiation of intervention

  • PROMIS Social

    PROMIS, or the Patient-Reported Outcomes Measurement Information System, uses T-scores to represent social health, with a mean of 50 and a standard deviation of 10 for the general US population. Higher T-scores generally indicate a greater amount of the measured concept, such as satisfaction with social roles and activities, while lower scores indicate less.

    at 3 months, 12 months, and 24 months following initiation of intervention

  • Radiographic Outcome

    evidence of bony healing, nonunion, or malunion of the fracture on imaging

    at 3 months, 6 months, 12 months, and 24 months following initiation of intervention

  • Complication Rate

    Rate of complications following initiation of management

    at 3 months, 6 months, 12 months, and 24 months following initiation of intervention

Study Arms (2)

Operative Management

ACTIVE COMPARATOR
Procedure: open reduction internal fixationProcedure: intramedullary nailProcedure: reverse total shoulder arthroplasty

Non-operative Management

NO INTERVENTION

Interventions

treatment with open reduction and plates/screws

Also known as: ORIF
Operative Management

open reduction and intramedullary nail

Also known as: IMN
Operative Management

reverse total shoulder arthroplasty

Also known as: RTSA
Operative Management

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • individuals 65 years of age or older with proximal humerus fractures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMass Chan Medical School

Worcester, Massachusetts, 01605, United States

Location

MeSH Terms

Conditions

Fractures, Bone

Interventions

Fracture Fixation, Intramedullary

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Fracture Fixation, InternalFracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Officials

  • Wayne Chan, MD

    UMass Chan Medical School

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gregory Iovanel, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 29, 2025

First Posted

July 11, 2025

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

October 20, 2025

Record last verified: 2025-10

Locations